Nov 27, 2014 at 16:52 | Source: CNBC-TV18
Sudarshan Sukhani of s2analytics.com is of the view that one can buy ONGC, Sun Pharma and Aurobindo Pharma.
Nov 27, 2014 at 15:43 | Source: CNBC-TV18
In a discussion on CNBC-TV18, Sudarshan Sukahni of s2analytics, Neeraj Deewan of Quantum Securities and Devang Mehta of Anand Rathi Financial Services share their views on the market and their preferred bets going ahead.
Nov 27, 2014 at 13:47 | Source: CNBC-TV18
Yogesh Mehta of Motilal Oswal Securities is of the view that Sun Pharmaceutical Industries may test Rs 880.
Nov 26, 2014 at 15:22 | Source: CNBC-TV18
Sudarshan Sukhani of s2analytics.com recommends buying Ambuja Cements, Sun Pharma and Mindtree.
Nov 26, 2014 at 14:33 | Source: Moneycontrol.com
Angel Broking has maintained a neutral rating on Sun Pharmaceutical Industries, in its November 14, 2014 research report.
Nov 26, 2014 at 11:50 | Source: CNBC-TV18
Sashi Krishnan is overweight on banking and financial sector. Among other sectors, he is bullish on pharmaceuticals and IT
Nov 26, 2014 at 11:01 | Source: Moneycontrol.com
According to Satish Gupta of astrostocktips, pharma stocks like Glenmark Pharma, Sun Pharma, Cipla, Biocon and Dr Reddys Lab's will be getting astrological support.
Nov 25, 2014 at 11:05 | Source: CNBC-TV18
Sanjay Dutt, Director at Quantum Securities is of the view that one may prefer Sun Pharmaceutical Industries.
Nov 25, 2014 at 10:07 | Source: Moneycontrol.com
Brokerage house KRChoksey has recommended a hold rating on Sun Pharmaceutical Industries with a target price of Rs 915 per share in its November 14, 2014 research report.
Nov 24, 2014 at 14:15 | Source: Moneycontrol.com
Sun Pharmaceutical Industries Ltd has informed BSE that the Hon'ble High Court of Gujarat at Ahmedabad, at its hearing held on November 14, 2014, has sanctioned the Scheme of Arrangement in the nature of Merger of Ranbaxy Laboratories Limited with Sun Pharmaceutical Industries Limited.